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Abstract
Background—Prognosis is worse in unmarried patients compared to married patients with heart
failure (HF). The reasons for differences in outcomes are unclear, but variations in medication
adherence may play a role, as medication adherence is essential to achieving better outcomes.
Objective—To determine whether medication adherence mediated the relationship between
marital status and cardiac event-free survival in patients with HF.
Method—Demographic, clinical and psychosocial data were collected by questionnaires and
medical record review for 136 HF patients (61 ± 11, 70% male, 60% NYHA III/IV). Medication
adherence was monitored objectively for 3 months using the Medication Event Monitoring
System. Cardiac event-free survival data were obtained by patient/family interview, hospital data
base and death certificate review. A series of regression and Cox-survival analyses were
performed to determine whether medication adherence mediated the relationship between marital
status and event-free survival.
Results—Cardiac event-free survival was worse in unmarried patients than married patients.
Unmarried patients were more likely to be nonadherent and were 2 times more likely to
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experience an event than married patients (p = .017). Marital status was not a significant predictor
of event-free survival after entering medication adherence in the model, demonstrating a
mediation effect of adherence on the relationship of marital status to survival.
Conclusion—Medication adherence mediated the relationship between marital status and event-
free survival. It is important to design interventions to increase medication adherence that take into
account subgroups, such as unmarried patients, who are at higher risk for nonadherence.
Keywords
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Introduction
Heart failure (HF) is a serious chronic condition that afflicts over 5.8 million people in the
United States (US).1 About 670,000 new cases are diagnosed each year for people who are
45 years of age and older.1 The HF incidence approaches 1% for those who are 65 years and
older.1 Therefore, due to an aging population and increased survival from cardiovascular
diseases, the number of patients with HF is expected to increase.
Medication adherence is crucial to achieve optimal HF outcomes.2-7 Patients with HF are
prone to exacerbations unless they consistently adhere to their medical regimen. Most
patients with HF are older with physical limitations. These patients often require assistance
to adhere to prescribed medication (e.g., transportation to physician’s office to keep the
prescription updated, transportation and money to refill the prescription, reminders to take
prescribed medications, and support to overcome cognitive changes and fatigue that could
affect their ability to take medications as prescribed).8-12 Without a spouse or partner,
patients with HF often have difficulty securing assistance for these needs.13
Rehospitalization and mortality rates are higher in unmarried patients with HF compared to
married patients.14, 15 Chin and Goldman15 followed 257 patients with HF and found that
single patients had significantly higher rates of readmission and death than married patients.
In a prospective study, other investigators identified marital quality as a predictor of
survival.14 The reasons for the difference in outcomes between married and unmarried
patients are unclear. Prior researchers have suggested that unmarried patients with HF have
lower adherence rates than married patients with HF.16-19 Likewise, we have already
reported that medication adherence20 and marital status21 independently predicted event-free
survival in patients with HF. However, we do not know whether differences in medication
adherence play a role in differences in outcomes between married and unmarried patients.
Accordingly, the purpose of this study was to determine whether medication adherence
mediates the relationship between marital status and cardiac event-free survival in patients
with HF. A mediator is a variable that helps to explain how or why the independent variable
predicts the outcome variable and enables investigators to explore the mechanism behind the
relationship between the independent variable and the outcome variables.22, 23 Moreover,
married patients tend to report more social support24, 25 and patients with more social
support have better medication adherence.26, 27 Investigators have postulated that it is not
marital status alone, but the interaction of marital status and social support that is related to
medication adherence.17, 18, 28 ENREF 44 Therefore, the relationships among marital status,
social support and medication adherence were also examined.
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This was secondary data analysis from a prospective, longitudinal study8, 20, 29, 30 in which
we examined whether the relationship between marital status and event-free survival was
explained by medication adherence in patients with HF.
Samples and Setting
Detailed eligibility criteria and recruitment methods have been published
previously.8, 20, 29, 30 ENREF 21 In short, patients were recruited from outpatient cardiology
clinics and inpatient cardiology wards in one Southern state. Patients with a confirmed
diagnosis of chronic HF who were on stable doses of HF medications were enrolled in the
study. Patients could have HF from either preserved or non-preserved systolic function.
Patients were excluded if they had obvious cognitive impairment (i.e., can’t give informed
consent or participate in an interview), or if they had a co-existing terminal illness expected
to affect study outcomes.
Variables and Measures
Marital status—Marital status was the independent variable in this study. Patient self-
reported marital status was collected by patient interview. Patients who were never married,
divorced, or widowed were categorized as unmarried. Those who were married or
cohabitated with a significant other were categorized as married.
Medication adherence—Medication adherence was assessed daily for 3 months using a
microelectronic medication monitoring device (Medication Event Monitoring System
[MEMS], AARDEX®-USA, Union City, CA). The MEMS registered each date and time the
cap was removed. Medication adherence from the MEMS was defined as the percentage of
days the correct number of doses were taken during the 3-month monitoring period.31
Patients who took the correct number of doses on at least 88% of days were categorized as
adherent, while all others were categorized as non-adherent. This cutpoint was chosen based
on research demonstrating that adherence at or above this level predicted better event-free
survival.30
Each patient was asked to put one HF prescription medication in the MEMS bottle. Priority
was given to medications taken twice a day. The beta-adrenergic antagonist agent was
chosen primarily as the drug to monitor, unless the patient was not prescribed one. In those
cases, the angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker
(ARB) was used. If the participant was not prescribed a beta-antagonist, or ACE inhibitor or
ARB, a diuretic or digoxin was monitored in the MEMS bottle. Prior researchers have
demonstrated that use of the MEMS to monitor only one medication is sufficient to reflect
medication taking behavior related to total patient medication regimens,32-34 that opening of
the bottle does reflect actual medication taking,32, 35 and that use of the MEMS does not
inflate adherence artificially.36 Each patient was given a MEMS diary to record unscheduled
cap openings (e.g., refilled the bottle without taking a dose, opened by accident). These
unscheduled openings were excluded when data were downloaded.
Cardiac event-free survival—The outcome variable was the composite end-point of
time to the first occurrence of one of the following events: cardiac ED visits, cardiac
hospitalizations and cardiac mortality (i.e., cardiac event-free survival). Data about cardiac
event-free survival were obtained by patient/family interview, hospital data base review and
review of death certificates and records. During data collection, the date and reasons for ED
visits, hospitalization and death were noted. If there was a difference between patient/family
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report and the hospital records, we carefully reviewed the medical record to confirm the visit
date and reason, and discussed the discrepancy with the patient or family.
Demographic variables—Age, gender, and education level were collected as
demographic variables. Patient age, gender, and education level were collected from patient
interview.
Clinical variables—Left ventricular ejection fraction (LVEF), New York Heart
Association (NYHA) functional class, body mass index (BMI), and medication-taking
behaviors were collected as clinical variables. LVEF was collected from the medical record
review. NYHA class was determined by standardized patient interview.37 Body mass index
was calculated as weight (kg)/height (m2). Medication-taking behaviors were measured by
the Medication Adherence Scale developed by our research team and validated in patients
with HF.38
Psychological variables—Perceived social support, anxiety, and depressive symptoms
were collected as psychological variables. Perceived social support was assessed using the
Multidimensional Perceived Social Support Scale (MPSSS). The MPSSS is a reliable and
valid instrument.39, 40 Internal consistency reliability of the MPSSS for this study was
demonstrated by a Cronbach’s alpha of .95. Anxiety was measured by the Anxiety Subscale
of the Brief Symptom Inventory (BSI). Depressive symptoms were assessed using the
Patient Health Questionnaire (PHQ). The BSI Anxiety subscale41 and PHQ-942, 43 have
established reliability and validity.
Procedure
The study received approval from the appropriate Institutional Review Boards and all
patients provided written, informed consent. Patient demographic, clinical, and
psychological data were collected at baseline and medication adherence monitoring with the
MEMS was initiated and continued for 3 months. Outcome data for hospitalizations and
cardiac event-survival were assessed up to 3.5 years by telephone interview and by
reviewing patient medical records.
Data Management and Analysis
All data analyses were performed using SPSS (Chicago, IL), version 17.0; a significance
level of .05 was chosen a priori. Data analysis began with a descriptive examination of all
variables, including frequency distributions, means, standard deviations, medians, and
interquartile ranges, as appropriate to the level of measurement of the variables.
Patients were divided into adherent and nonadherent groups based on their medication
adherence rate measured by the MEMS using a cutpoint of 88%30 and into married or un-
married groups. Logistic regressions and t-tests were used to examine the relationships
among marital status, social support and medication adherence. The log-rank test was used
to compare the time to event-free survival between patients in married and un-married
groups. Kaplan-Meier plots were used to graphically depict group differences in event-free
survival. Cox proportional hazards regression modeling was used to assess the time to event-
free survival between these two groups with and without controlling for the following
potential covariates: age, gender, education level, LVEF, NYHA class, perceived social
support, anxiety, and depressive symptoms.
To test whether medication adherence was a mediator of the relationship between marital
status and event-free survival, a series of regression models and Cox-survival analyses were
conducted. The test for mediation followed the steps outlined by Baron et al.22, 23, 44, 45
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Four regression models were performed to test for the mediator effect. The first model tested
whether marital status (the independent variable) was a predictor of medication adherence
(mediator). The second model tested whether medication adherence was a predictor of
event-free survival (outcome variable). The third model tested whether marital status was a
predictor of event-free survival. In the fourth model, both marital status and medication
adherence (independent and mediator variables) were entered simultaneously as predictors
of event-free survival (outcome variable). The following conditions had to be met for a
mediator effect to be present: 1) the first, second, and the third models were significant, and
2) the p value of the coefficient associated with the independent variable (marital status) in
the fourth model was higher (partial mediator) or was non-significant (full mediator)
compared to the p value in the third model.22, 23, 46
Results
Patient Characteristics
A total of 136 patients with HF and complete MEMS data were included in the analysis. The
mean age of patients in the sample was 61 ± 11 years and about two thirds of patients had
advanced HF (NYHA class III or IV) with an average LVEF of 35 ± 14%. The majority of
the patients were male (70%) and Caucasian (90%). One quarter of the patients did not
complete high school.
A majority of participants were married (62%). Significantly more male patients were
married (78.6%) than female patients (21.4%) (p = .007). There were no group differences
based on support from government insurance (i.e., Medicare or Medicaid), financial status,
BMI, or co-morbidities (i.e., diabetes, hypertension, previous myocardial infarction and
stroke). Full sample characteristics and comparisons of married vs. unmarried groups are
presented in Table 1.
Marital status, perceived social support, and medication adherence
Of the total sample, 56% were classified as adherent. Sixty-three percent of married patients
were classified as adherent, while only 44% of unmarried patients were classified adherent
(p = .035). Compared to married patients, those who were unmarried were 2.2 times more
likely to be nonadherent to their prescribed medication (p = .033). Married patients
perceived more social support compared to unmarried patients (70.8 vs. 58.8, p = .001);
likewise, adherent patients had higher perceived social support scores than nonadherent
patients (69.1 vs. 62.8, p = .049). More married patients reported having someone usually
remind them to take their prescribed medications compared to unmarried patients (p = .036).
Also, more married patients reported having someone to help them take their prescribed
medications than unmarried patients (p < .001).
Marital status, medication adherence and event-free survival
There was 1 HF death (.7%), 31 (22.8%) cardiac-related hospital admissions, and 6 (4.4%)
ED visits due to cardiac reason. There was no difference in cardiac mortality rates between
unmarried and married patients (2% vs. 0%, p = .959). The rate of cardiac hospitalizations
was higher in unmarried patients than married patients (31% vs. 18%, p = .035). In Kaplan-
Meier analysis, the composite endpoint of cardiac event-free survival was significantly
shorter in unmarried patients than in married patients (706 days vs 873 days, p = .034,
Figure 1).
In a series of regression models and Cox-survival analyses, medication adherence mediated
the relationship between marital status and event-free survival based on the following
sequence of regression analyses. First, in Path A (Figure 2), marital status independently
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predicted medication adherence (p = .033). Second, in Path B, patients who were
nonadherent had 3.1 times greater risk of a cardiac event than adherent patients (p < .001).
Third, in Path C, marital status was an independent predictor of cardiac event-free survival.
Patients who were unmarried had 2 times the risk of experiencing a cardiac event than
patients who were married, before and after adjusting for age, gender, education level,
LVEF, NYHA class, BMI, perceived social support, anxiety, and depressive symptoms
(Table 2). In the final Path D, marital status was no longer a significant predictor of event-
free survival when medication adherence was entered into the model (p = .08), indicating
medication adherence is why married patients have better event-free survival. Married
patients were more likely to be adherent to their prescribed medication and therefore had a
longer cardiac event-free survival.
We also conduct the analyses with medication adherence as a continuous variable. In Path
A, marital status independently predicted medication adherence (p = .004). In Path B,
medication adherence predicted cardiac event-free survival (p = .011). In the Path C, marital
status predicted cardiac event-free survival (p = .017). In the final Path D, marital status was
no longer a significant predictor of event-free survival when medication adherence was
entered into the model (p = .139). These analyses indicated that medication adherence truly
was a mediator between marital status and cardiac event-free survival when analyzed as
either a dichotomized or continuous variable.
Discussion
This is the first study to examine mediation between marital status and outcomes in patients
with HF. Unmarried patients with HF had a higher risk of cardiac events21 than married
patients. Nonadherent patients had greater risk for having an event compared to adherent
patients.20, 30 Our study extends these findings by demonstrating that that medication
adherence mediates the relationship between marital status and outcomes in patients with
HF.
Our results are consistent with other studies in which the rates of cardiac events were higher
in unmarried patients compare to married patients with HF,14, 15, 21 and those with
myocardial infarction.13 Chin and Goldman found that HF patients who were single were
more likely to be readmitted to the hospital or die (HR = 2.1, 95% CI = 1.3 to 3.3).15 Coyne
et al.14 followed 189 patients with HF for four years and reported that marital status was a
predictor of event-free survival in patients with HF (HR = 2.72).21 Marital quality was also a
predictor of survival in these patients. In a prospective study of 1,401 patients with
myocardial infarction,13 unmarried patients had a significantly higher mortality rate than
married patients, both in-hospital and after discharge.
Investigators have suggested that better outcomes of married patients might be associated
with greater patient adherence to medical therapy and lifestyle recommendations.14, 47 The
major finding of our study was that married patients were more likely to be adherent to
prescribed medications, which was also the strongest predictor of better outcomes. Prior
studies of the relationship between marital status and medication adherence have produced
inconsistent results.17-19, 26, 48-50 While no prior investigator examined the relationship
between marital status and medication adherence in HF, seven research studies have been
published in patients with other chronic conditions.17-19, 26, 48-50 In four of the seven
studies, the investigators reported no differences in medication adherence based on marital
status.26, 48-50 However, in a study of 1,326 patients with coronary artery disease, unmarried
patients were more likely to discontinue taking medications against their doctor’s advice.17
Likewise, in two other studies, unmarried participants were less adherent to prescribed
medication than married participants.18, 19 It is unclear why married patients are more likely
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to be adherent than unmarried patients. Investigators have suggested one reason may be that
spouses facilitate adherence by providing practical support.17, 18 Rich et al. suggested that
the presence of a spouse or other caregiver may increase adherence through direct
supervision of medication administration.28 It appears that without the help of their family
members, patients have difficulty adhering to their medication regimen, keeping their
physician appointments, and following their medical plan.9, 10, 16, 51 In our study, compared
to unmarried patients, married patients more often reported having someone usually remind
them about taking their prescribed medications. They also more often reported having
someone help them take their medication. Married patients perceived more social support
and received more reminders and help from their spouses or partners than unmarried
patients. Under these circumstances, it may not be surprising that married patients have
better medication adherence compared to unmarried patients with HF.
In our study, medication adherence emerged as a mediator between marital status and poorer
outcomes. When we compared sociodemographic and clinical variables between married
and unmarried participants, gender, perceived social support and medication adherence were
different between these two groups. Although the unmarried group had more female
participants than the married group, gender was not related to event-free survival. This result
is consistent with prior studies showing no gender difference in rehospitalization or
mortality in HF.52, 53
Limitations
There are a few limitations that might compromise the generalizability of the findings. First,
we did not measure quality of the marital relationship. A poor quality marital relationship
might cause more stress in daily life and exacerbate HF.14 ENREF 15 Further research is
needed to examine quality of marriage, medication adherence and outcomes in patients with
HF. It is also possible that married patients more closely followed a low salt diet or engaged
in more physical activity compared to unmarried patients. However, these factors were not
measured in this study. Inclusion of other potential factors related to marital status and
medication adherence in future studies will provide further insight into the relationships
among marital status, medication adherence and outcomes.
There were more male patients who were married in our study than female married patients.
Although this may limit our ability to generalize the results to married females, we did
adjust for gender in the multiple Cox regression. Finally, patients with HF need to take their
prescribed medications for the remainder of their lives. It is possible that our 3 month
monitoring period did not reflect long-term medication adherence. However, we feel that a
3-month period could also be an advantage. We were able to observe a medication-taking
behavior pattern that affected cardiac event-free survival without placing too much burden
on the research participants. Further longer-term measurement of medication adherence
using the MEMS would be useful to confirm the findings from this study.
Conclusion
The major finding of this study was that medication adherence was a mediator of the
relationship between marital status and cardiac event-free survival in this sample. Thus,
determining patient marital status can help to identify those who are at higher risk of worse
medication adherence and poorer outcomes. It is important to design interventions to
improve medication adherence and outcomes that take into account subgroups, such as
unmarried patients, who are at higher risk for nonadherence and poorer outcomes.
Wu et al. Page 7














This study was supported by funding from the Philips Medical-American Association of Critical Care Nurses
Outcomes Grant, American Heart Association Great River Affiliate Post-doctoral Fellowship to Jia-Rong Wu,
University of Kentucky General Clinical Research Center (M01RR02602), grant # R01 NR008567 from the
National Institute of Nursing Research and a Center grant to the University of Kentucky, College of Nursing from
NIH, NINR, 1P20NR010679. The content is solely the responsibility of the authors and does not necessarily
represent the official views of the National Institute of Nursing Research or the National Institutes of Health.
References
1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and
stroke statistics--2010 update: A report from the american heart association. Circulation. 2010;
121:e46–e215. [PubMed: 20019324]
2. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart
failure. Am. J. Public Health. 1997; 87:643–648. [PubMed: 9146445]
3. Chui MA, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, et al. Association between adherence to
diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy. 2003;
23:326–332. [PubMed: 12627931]
4. Happ MB, Naylor MD, Roe-Prior P. Factors contributing to rehospitalization of elderly patients
with heart failure. J. Cardiovasc. Nurs. 1997; 11:75–84. [PubMed: 9200021]
5. Joshi PP, Mohanan CJ, Sengupta SP, Salkar RG. Factors precipitating congestive heart failure--role
of patient non-compliance. J. Assoc. Physicians India. 1999; 47:294–295. [PubMed: 10999123]
6. Li H, Morrow-Howell N, Proctor EK. Post-acute home care and hospital readmission of elderly
patients with congestive heart failure. Health Soc. Work. 2004; 29:275–285. [PubMed: 15575455]
7. Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance
on hospitalization and mortality in patients with heart failure in long-term therapy: A prospective
cohort study. Eur. J. Clin. Pharmacol. 2001; 57:77–83. [PubMed: 11372597]
8. Wu JR, Moser DK, Chung ML, Lennie TA. Predictors of medication adherence using a
multidimensional adherence model in patients with heart failure. J. Card. Fail. 2008; 14:603–614.
[PubMed: 18722327]
9. Riegel B, Moser DK, Anker SD, Appel LJ, Dunbar SB, Grady KL, et al. State of the science:
Promoting self-care in persons with heart failure: A scientific statement from the american heart
association. Circulation. 2009; 120:1141–1163. [PubMed: 19720935]
10. Wu JR, Moser DK, Lennie TA, Peden AR, Chen YC, Heo S. Factors influencing medication
adherence in patients with heart failure. Heart Lung. 2008; 37:8–16. [PubMed: 18206522]
11. Thornhill K, Lyons AC, Nouwen A, Lip GY. Experiences of living with congestive heart failure: A
qualitative study. Br J Health Psychol. 2008; 13:155–175. [PubMed: 18230240]
12. Riegel B, Carlson B. Facilitators and barriers to heart failure self-care. Patient Educ. Couns. 2002;
46:287–295. [PubMed: 11932128]
13. Chandra V, Szklo M, Goldberg R, Tonascia J. The impact of marital status on survival after an
acute myocardial infarction: A population-based study. Am. J. Epidemiol. 1983; 117:320–325.
[PubMed: 6829559]
14. Coyne JC, Rohrbaugh MJ, Shoham V, Sonnega JS, Nicklas JM, Cranford JA. Prognostic
importance of marital quality for survival of congestive heart failure. Am. J. Cardiol. 2001;
88:526–529. [PubMed: 11524062]
15. Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive
heart failure. Am. J. Cardiol. 1997; 79:1640–1644. [PubMed: 9202355]
16. DiMatteo MR. Social support and patient adherence to medical treatment: A meta-analysis. Health
Psychol. 2004; 23:207–218. [PubMed: 15008666]
17. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with
cardiovascular drug regimens. Am. Heart J. 2006; 151:185–191. [PubMed: 16368315]
18. Trivedi RB, Ayotte B, Edelman D, Bosworth HB. The association of emotional well-being and
marital status with treatment adherence among patients with hypertension. J. Behav. Med. 2008;
31:489–497. [PubMed: 18780175]
Wu et al. Page 8













19. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in
acne. Br. J. Dermatol. 2005; 152:1015–1021. [PubMed: 15888162]
20. Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported,
medication adherence independently predicts event-free survival in patients with heart failure. J.
Card. Fail. 2008; 14:203–210. [PubMed: 18381183]
21. Chung ML, Lennie TA, Riegel B, Wu JR, Dekker RL, Moser DK. Marital status as an independent
predictor of event-free survival of patients with heart failure. Am. J. Crit. Care. 2009; 18:562–570.
[PubMed: 19880958]
22. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological
research: Conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986;
51:1173–1182. [PubMed: 3806354]
23. Bennett JA. Mediator and moderator variables in nursing research: Conceptual and statistical
differences. Res. Nurs. Health. 2000; 23:415–420. [PubMed: 11052395]
24. Sherbourne CD, Hays RD. Marital status, social support, and health transitions in chronic disease
patients. J. Health Soc. Behav. 1990; 31:328–343. [PubMed: 2135935]
25. Barron CR, Foxall MJ, Von Dollen K, Jones PA, Shull KA. Marital status, social support, and
loneliness in visually impaired elderly people. J. Adv. Nurs. 1994; 19:272–280. [PubMed:
8188958]
26. Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, et al. Prevalence
and correlates of poor medication adherence amongst psychiatric outpatients in southwestern
nigeria. Gen. Hosp. Psychiatry. 2009; 31:167–174. [PubMed: 19269538]
27. Molloy GJ, Perkins-Porras L, Bhattacharyya MR, Strike PC, Steptoe A. Practical support predicts
medication adherence and attendance at cardiac rehabilitation following acute coronary syndrome.
J. Psychosom. Res. 2008; 65:581–586. [PubMed: 19027448]
28. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary
intervention on medication compliance in elderly patients with congestive heart failure. Am. J.
Med. 1996; 101:270–276. [PubMed: 8873488]
29. Wu JR, Lennie TA, De Jong MJ, Frazier SK, Heo S, Chung ML, et al. Medication adherence is a
mediator of the relationship between ethnicity and event-free survival in patients with heart failure.
J. Card. Fail. 2010; 16:142–149. [PubMed: 20142026]
30. Wu JR, Moser DK, De Jong MJ, Rayens MK, Chung ML, Riegel B, et al. Defining an evidence-
based cutpoint for medication adherence in heart failure. Am. Heart J. 2009; 157:285–291.
[PubMed: 19185635]
31. Chung ML, Lennie TA, de Jong M, Wu JR, Riegel B, Moser DK. Patients differ in their ability to
self-monitor adherence to a low-sodium diet versus medication. J. Card. Fail. 2008; 14:114–120.
[PubMed: 18325457]
32. Cheng CW, Woo KS, Chan JC, Tomlinson B, You JH. Association between adherence to statin
therapy and lipid control in hong kong chinese patients at high risk of coronary heart disease. Br. J.
Clin. Pharmacol. 2004; 58:528–535. [PubMed: 15521901]
33. Dunbar-Jacob J, Bohachick P, Mortimer MK, Sereika SM, Foley SM. Medication adherence in
persons with cardiovascular disease. J. Cardiovasc. Nurs. 2003; 18:209–218. [PubMed: 12837011]
34. Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge,
and skills with emergency department visits by adults 50 years or older with congestive heart
failure. Am. J. Health. Syst. Pharm. 2004; 61:2043–2049. [PubMed: 15509127]
35. Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, et al. The influence of patient
adherence on anticoagulation control with warfarin: Results from the international normalized
ratio adherence and genetics (in-range) study. Arch. Intern. Med. 2007; 167:229–235. [PubMed:
17296877]
36. Wagner GJ, Ghosh-Dastidar B. Electronic monitoring: Adherence assessment or intervention? HIV
clinical trials. 2002; 3:45–51. [PubMed: 11819185]
37. Mills RM Jr. Haught WH. Evaluation of heart failure patients: Objective parameters to assess
functional capacity. Clin. Cardiol. 1996; 19:455–460. [PubMed: 8790948]
Wu et al. Page 9













38. Wu JR, Chung M, Lennie TA, Hall LA, Moser DK. Testing the psychometric properties of the
medication adherence scale in patients with heart failure. Heart Lung. 2008; 37:334–343.
[PubMed: 18790334]
39. Canty-Mitchell J, Zimet GD. Psychometric properties of the multidimensional scale of perceived
social support in urban adolescents. Am. J. Community Psychol. 2000; 28:391–400. [PubMed:
10945123]
40. Picardi A, Mazzotti E, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF, et al. Stress, social
support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics. 2005;
46:556–564. [PubMed: 16288135]
41. Derogatis LR, Melisaratos N. The brief symptom inventory: An introductory report. Psychol. Med.
1983; 13:595–605. [PubMed: 6622612]
42. Kroenke K, Spitzer RL, Williams JB. The phq-9: Validity of a brief depression severity measure. J.
Gen. Intern. Med. 2001; 16:606–613. [PubMed: 11556941]
43. Ackermann RT, Rosenman MB, Downs SM, Holmes AM, Katz BP, Li J, et al. Telephonic case-
finding of major depression in a medicaid chronic disease management program for diabetes and
heart failure. Gen. Hosp. Psychiatry. 2005; 27:338–343. [PubMed: 16168794]
44. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to
test mediation and other intervening variable effects. Psychol Methods. 2002; 7:83–104. [PubMed:
11928892]
45. MacKinnon DP, MacKinnon DP, Dwyer JH. Estimating mediated effects in prevention studies.
Eval. Rev. 1993; 17:144–158.
46. Sonnentag S, Zijlstra FR. Job characteristics and off-job activities as predictors of need for
recovery, well-being, and fatigue. J. Appl. Psychol. 2006; 91:330–350. [PubMed: 16551187]
47. Krumholz HM, Butler J, Miller J, Vaccarino V, Williams CS, Mendes de Leon CF, et al.
Prognostic importance of emotional support for elderly patients hospitalized with heart failure.
Circulation. 1998; 97:958–964. [PubMed: 9529263]
48. Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment
adherence and knowledge of tb transmission among patients on tb treatment. BMC Public Health.
2004; 4:68. [PubMed: 15625004]
49. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-in-physician
and race are predictors of adherence to medical management in inflammatory bowel disease.
Inflamm. Bowel Dis. 2009; 15:1233–1239. [PubMed: 19177509]
50. Silva MC, Ximenes RA, Filho DB Miranda, Arraes LW, Mendes M, Melo AC, et al. Risk-factors
for non-adherence to antiretroviral therapy. Rev. Inst. Med. Trop. Sao Paulo. 2009; 51:135–139.
[PubMed: 19551287]
51. Sayers SL, Riegel B, Pawlowski S, Coyne JC, Samaha FF. Social support and self-care of patients
with heart failure. Ann. Behav. Med. 2008; 35:70–79. [PubMed: 18347906]
52. Diercks DB, Fonarow GC, Kirk JD, Emerman CL, Hollander JE, Weber JE, et al. Risk
stratification in women enrolled in the acute decompensated heart failure national registry
emergency module (adhere-em). Acad. Emerg. Med. 2008; 15:151–158. [PubMed: 18275445]
53. Mullens W, Abrahams Z, Sokos G, Francis GS, Starling RC, Young JB, et al. Gender differences
in patients admitted with advanced decompensated heart failure. Am. J. Cardiol. 2008; 102:454–
458. [PubMed: 18678305]
Wu et al. Page 10














Kaplan-Meier survival plot of marital status and event-free survival
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Medication adherence is a mediator between marital status and event-free survival
Path A: Test of whether marital status is a predictor of medication adherence.
Path B: Test of whether medication adherence is a predictor of cardiac event-free survival.
Path C: Test of whether marital status is a predictor of cardiac event-free survival.
Path D: Test of whether marital status and medication adherence together are predictors of
cardiac event-free survival.
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Table 1
Sample Characteristics and comparison of married vs. unmarried groups




(n = 52) p
Age, years 61 (11) 60 (11) 62 (11) .32
Female 41 (30.1) 18 (21.4) 23 (44.2) .01
Education 12.6 (3.3) 12.4 (3.5) 12.8 (2.8) .45
Financial status .41
 Comfortable 33 (24.6) 23 (27.7) 10 (19.6)
 Enough to make ends meet 71 (53.0) 44 (53.0) 27 (52.9)
 Not enough to make ends meet 30 (22.4) 16 (19.3) 14 (27.5)
With government or commercial insurance
 With government insurance 106 (77.9) 66 (78.6) 40 (76.9) .83
LVEF, % 34.6 (14.1) 33.7 (13.6) 36.1 (15.1) .34
NYHA functional class .19
  I/II 54 (39.7) 34 (40.4) 20 (38.4)
  III 63 (46.3) 42 (50.0) 21 (40.4)
  IV 19 (14.0) 8 (9.5) 11 (21.2)
Charlson comorbidity index 3.3 (1.7) 3.3 (1.7) 3.5 (1.6) .51
Hypertension 104 (79.4) 64 (79.0) 40 (80.0) 1.00
Diabetes 64 (47.8) 37 (45.1) 27 (51.9) .48
Stroke 25 (18.7) 16 (19.5) 9 (17.3) .82
Previous MI 80 (61.1) 49 (61.3) 31 (60.8) 1.0
BMI 31.8 (6.6) 32.3 (6.7) 31.1 (6.5) .32
Taking BB 121 (89.0) 76 (90.5) 45 (86.5) .58
Perceived social support 66.3 (18.4) 70.8 (15.1) 58.8 (21.0) .01
Anxiety .73 (.75) .74 (.69) .72 (.86) .89
Depressive symptoms 7.0 (.59) 6.7 (5.7) 7.3 (6.2) .61
Medication adherence 80.7 (22.8) 85.1 (18.2) 73.7 (27.4) .01
Data are presented as means (SD), or N (%), interval level data compared by independent t-test, nominal and categorical by Chi-square; BB = beta
blocker; LVEF = left ventricular ejection fraction; MI = myocardial infarction; NYHA = New York Heart Association
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Table 2
Cox Regression Modeling: Marital Status on Cardiac Event-free Survival (N = 136)
Variables Hazard Ratio 95% CI p
Simple Cox Regression
Marital status 2.13 1.15-3.94 .017
Multiple Cox Regression
Step1
Age .98 .95-1.02 .349
Gender .70 .30-1.63 .405
Education level 1.00 .85-1.17 .965
LVEF .99 .96-1.02 .508
NYHA 1.19 .77-1.84 .441
BMI .93 .87-.99 .021
Perceived social support 1.00 .98-1.02 .793
Anxiety 1.15 .75-1.77 .529
Depressive symptoms 2.31 1.01-5.31 .048
Step2
Marital status 2.04 1.02-4.07 .044
Step3
Medication adherence 3.23 1.57-6.62 .001
BMI = Body Mass Index; CI = confidence interval; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association
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